{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-171921","form_type":"8-K","ticker":"CUE","cik":"0001645460","company_name":"Cue Biopharma, Inc.","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.615563+00:00","generated_at":"2026-06-25T02:47:01.235610+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Cue Biopharma reports 2022 annual meeting voting results","bullets":["All seven director nominees elected (Driscoll, Fletcher, Gray, Howson, Kiener, Morich, Passeri).","Ratification of RSM US LLP as independent auditor for FY 2022 approved with 26,125,468 votes for.","Broker non-votes of 14,293,960 on director elections; no other proposals were voted on.","Meeting held June 9, 2022; results filed on June 10, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-171921","json":"https://secwatch.observer/filing/0001193125-22-171921.json","markdown":"https://secwatch.observer/filing/0001193125-22-171921.md","text":"https://secwatch.observer/filing/0001193125-22-171921.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645460/000119312522171921/0001193125-22-171921-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645460/000119312522171921/d370247d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:47:01.235610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}